379 related articles for article (PubMed ID: 32435660)
1. Realising the therapeutic potential of neuroactive steroid modulators of the GABA
Belelli D; Hogenkamp D; Gee KW; Lambert JJ
Neurobiol Stress; 2020 May; 12():100207. PubMed ID: 32435660
[TBL] [Abstract][Full Text] [Related]
2. Relating neurosteroid modulation of inhibitory neurotransmission to behaviour.
Belelli D; Phillips GD; Atack JR; Lambert JJ
J Neuroendocrinol; 2022 Feb; 34(2):e13045. PubMed ID: 34644812
[TBL] [Abstract][Full Text] [Related]
3. Neurosteroid Modulation of Synaptic and Extrasynaptic GABA
Mitchell SJ; Phillips GD; Tench B; Li Y; Belelli D; Martin SJ; Swinny JD; Kelly L; Atack JR; Paradowski M; Lambert JJ
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672476
[TBL] [Abstract][Full Text] [Related]
4. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy.
Reddy DS; Mbilinyi RH; Estes E
Psychopharmacology (Berl); 2023 Sep; 240(9):1841-1863. PubMed ID: 37566239
[TBL] [Abstract][Full Text] [Related]
5. Neurosteroids: endogenous allosteric modulators of GABA(A) receptors.
Lambert JJ; Cooper MA; Simmons RD; Weir CJ; Belelli D
Psychoneuroendocrinology; 2009 Dec; 34 Suppl 1():S48-58. PubMed ID: 19758761
[TBL] [Abstract][Full Text] [Related]
6. Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond.
Zorumski CF; Paul SM; Covey DF; Mennerick S
Neurobiol Stress; 2019 Nov; 11():100196. PubMed ID: 31649968
[TBL] [Abstract][Full Text] [Related]
7. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.
Marecki R; Kałuska J; Kolanek A; Hakało D; Waszkiewicz N
Front Psychiatry; 2023; 14():1298359. PubMed ID: 38116383
[TBL] [Abstract][Full Text] [Related]
8. Neurosteroid modulation of GABAA receptors.
Lambert JJ; Belelli D; Peden DR; Vardy AW; Peters JA
Prog Neurobiol; 2003 Sep; 71(1):67-80. PubMed ID: 14611869
[TBL] [Abstract][Full Text] [Related]
9. [GABAergic approach of postpartum depression: A translational review of literature].
Verbe J; Dubertret C; El-Hage W; Bonnet-Brilhault F; Duriez P
Encephale; 2020 Apr; 46(2):123-134. PubMed ID: 31767256
[TBL] [Abstract][Full Text] [Related]
10. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women.
Reddy DS
J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of endogenous neuroactive steroids.
Reddy DS
Crit Rev Neurobiol; 2003; 15(3-4):197-234. PubMed ID: 15248811
[TBL] [Abstract][Full Text] [Related]
12. Developmentally regulated neurosteroid synthesis enhances GABAergic neurotransmission in mouse thalamocortical neurones.
Brown AR; Herd MB; Belelli D; Lambert JJ
J Physiol; 2015 Jan; 593(1):267-84. PubMed ID: 25556800
[TBL] [Abstract][Full Text] [Related]
13. Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
Walton N; Maguire J
Neurobiol Stress; 2019 Nov; 11():100198. PubMed ID: 31709278
[TBL] [Abstract][Full Text] [Related]
14. Development of neuroactive steroids for the treatment of postpartum depression.
Gunduz-Bruce H; Takahashi K; Huang MY
J Neuroendocrinol; 2022 Feb; 34(2):e13019. PubMed ID: 34462985
[TBL] [Abstract][Full Text] [Related]
15. Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.
Manzella FM; Covey DF; Jevtovic-Todorovic V; Todorovic SM
J Neuroendocrinol; 2022 Feb; 34(2):e13086. PubMed ID: 35014105
[TBL] [Abstract][Full Text] [Related]
16. [Perspectives of neurosteroid derivative application in antiepileptic therapy].
Borowicz KK; Czuczwar SJ
Przegl Lek; 2005; 62(11):1293-5. PubMed ID: 16512623
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol.
Finn DA; Jimenez VA
Handb Exp Pharmacol; 2018; 248():55-78. PubMed ID: 29242992
[TBL] [Abstract][Full Text] [Related]
18. Synthetic neurosteroids on brain protection.
Rey M; Coirini H
Neural Regen Res; 2015 Jan; 10(1):17-21. PubMed ID: 25788907
[TBL] [Abstract][Full Text] [Related]
19. Neurosteroid modulation of synaptic and extrasynaptic GABA(A) receptors.
Herd MB; Belelli D; Lambert JJ
Pharmacol Ther; 2007 Oct; 116(1):20-34. PubMed ID: 17531325
[TBL] [Abstract][Full Text] [Related]
20. Neurosteroid modulation of recombinant and synaptic GABAA receptors.
Lambert JJ; Harney SC; Belelli D; Peters JA
Int Rev Neurobiol; 2001; 46():177-205. PubMed ID: 11599300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
